Glauconix Biosciences

About:

Glauconix Biosciences is a pharmaceutical research company that uses technology to lower the cost of ophthalmic drug development.

Website: https://glauconix-biosciences.com/

Top Investors: National Science Foundation, Excell Partners, Eastern New York Angels

Description:

Glauconix Biosciences is a pharmaceutical research company. It also develops ex-vivo dynamic 3D human tissue models for ophthalmic drug discovery. They provide species-relevant models that integrate human genetics and closely resemble actual human physiology to enable rapid testing and discovery across diverse population genetics.

Total Funding Amount:

$2.23M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Albany, New York, United States

Founded Date:

2014-01-01

Founders:

Karen Y. Torrejon

Number of Employees:

1-10

Last Funding Date:

2018-05-31

IPO Status:

Private

Industries:

© 2025 bioDAO.ai